AbCellera Biologics Inc. (ABCL)
USD 2.07
(-1.2%)
USD 2.07
(-1.2%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 335.77 Million USD | 9.15% |
| 2022 | 307.63 Million USD | 5.05% |
| 2021 | 292.83 Million USD | 67.31% |
| 2020 | 175.02 Million USD | 1222.37% |
| 2019 | 13.23 Million USD | 33.93% |
| 2018 | 9.88 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 177.32 Million USD | -20.34% |
| 2024 Q3 | 314.73 Million USD | 77.49% |
| 2024 Q1 | 222.6 Million USD | -33.7% |
| 2023 Q3 | 329.41 Million USD | -3.78% |
| 2023 FY | 335.77 Million USD | 9.15% |
| 2023 Q2 | 342.33 Million USD | 18.28% |
| 2023 Q1 | 289.41 Million USD | -5.92% |
| 2023 Q4 | 335.77 Million USD | 1.93% |
| 2022 Q2 | 380.92 Million USD | -1.0% |
| 2022 Q1 | 384.78 Million USD | 31.4% |
| 2022 FY | 307.63 Million USD | 5.05% |
| 2022 Q4 | 307.63 Million USD | 1.78% |
| 2022 Q3 | 302.23 Million USD | -20.66% |
| 2021 FY | 292.83 Million USD | 67.31% |
| 2021 Q1 | 171.39 Million USD | -2.07% |
| 2021 Q4 | 292.83 Million USD | 33.51% |
| 2021 Q3 | 219.33 Million USD | 19.09% |
| 2021 Q2 | 184.17 Million USD | 7.46% |
| 2020 Q4 | 175.02 Million USD | 229.33% |
| 2020 Q1 | - USD | -100.0% |
| 2020 FY | 175.02 Million USD | 1222.37% |
| 2020 Q3 | 53.14 Million USD | -17.37% |
| 2020 Q2 | 64.32 Million USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 13.23 Million USD | 33.93% |
| 2019 Q4 | 13.23 Million USD | 0.0% |
| 2018 FY | 9.88 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alkermes plc | 933.53 Million USD | 64.032% |
| Agenus Inc. | 462.29 Million USD | 27.368% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 91.71% |
| Aptorum Group Limited | 5.25 Million USD | -6287.535% |
| Ardelyx, Inc. | 130.76 Million USD | -156.782% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 29.811% |
| Bicycle Therapeutics plc | 224.41 Million USD | -49.625% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -157.873% |
| ChromaDex Corporation | 26.5 Million USD | -1166.697% |
| Chimerix, Inc. | 19.74 Million USD | -1600.562% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -854.53% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -362.712% |
| CRISPR Therapeutics AG | 346.76 Million USD | 3.17% |
| Precision BioSciences, Inc. | 140.92 Million USD | -138.274% |
| Dyadic International, Inc. | 2.34 Million USD | -14245.411% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -1964.662% |
| Fortress Biotech, Inc. | 165.93 Million USD | -102.349% |
| Lantern Pharma Inc. | 2.73 Million USD | -12156.021% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -369.748% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -9415.505% |
| Incyte Corporation | 1.59 Billion USD | 78.912% |
| IO Biotech, Inc. | 17.55 Million USD | -1812.6% |
| Jaguar Health, Inc. | 45.86 Million USD | -632.08% |
| Novavax, Inc. | 2.57 Billion USD | 86.946% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -831.211% |
| Opthea Limited | 264.6 Million USD | -26.899% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -156.892% |
| ContextLogic Inc. | 206 Million USD | -62.998% |
| MiMedx Group, Inc. | 96.33 Million USD | -248.568% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -599.213% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -9415.068% |
| NextCure, Inc. | 14.99 Million USD | -2138.954% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -8207.175% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -4928.845% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -618.406% |
| Vaxcyte, Inc. | 167.44 Million USD | -100.524% |
| PDS Biotechnology Corporation | 33.25 Million USD | -909.575% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -42.753% |
| Pharming Group N.V. | 244.07 Million USD | -37.572% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -2716.44% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -162.754% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -4981.91% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -4981.91% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -307.332% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -4954.584% |
| Acelyrin, Inc. | 86.35 Million USD | -288.841% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -25744.012% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -2235.183% |
| Summit Therapeutics Inc. | 125.25 Million USD | -168.07% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -3442.315% |
| Senti Biosciences, Inc. | 52.57 Million USD | -538.71% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -388.21% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -121.617% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -17066.462% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -25041.139% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -48.028% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -3484.67% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -47.63% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 32.099% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -2976.562% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -1120.515% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -2673.931% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 30.996% |
| Immix Biopharma, Inc. | 3.72 Million USD | -8921.912% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -788.014% |
| MEI Pharma, Inc. | 8.35 Million USD | -3918.863% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1057.25% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | 3.396% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -130.19% |
| Fortress Biotech, Inc. | 165.93 Million USD | -102.349% |
| Precigen, Inc. | 41.64 Million USD | -706.301% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -572.493% |
| AlloVir, Inc. | 45.01 Million USD | -645.92% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -157.621% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -143.669% |
| ImmuCell Corporation | 18.81 Million USD | -1684.616% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1089.598% |
| Onconetix, Inc. | 23.18 Million USD | -1348.504% |
| PureTech Health plc | 125.58 Million USD | -167.374% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -3651.687% |
| Elevation Oncology, Inc. | 34.28 Million USD | -879.453% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -13633.17% |
| Seer, Inc. | 39.36 Million USD | -752.981% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -443.028% |
| Innoviva, Inc. | 568.55 Million USD | 40.942% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -1133.201% |
| ESSA Pharma Inc. | 3.49 Million USD | -9507.13% |
| GlycoMimetics, Inc. | 6.9 Million USD | -4764.857% |
| GT Biopharma, Inc. | 6.63 Million USD | -4962.204% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -27.0% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -23.317% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -299.61% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -3335.4% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -1135.879% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -10309.164% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -355.185% |
| Aptose Biosciences Inc. | 15.8 Million USD | -2023.995% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -2941.536% |
| Soligenix, Inc. | 7.27 Million USD | -4515.539% |
| Century Therapeutics, Inc. | 175.94 Million USD | -90.846% |
| Kura Oncology, Inc. | 51.66 Million USD | -549.948% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -176.856% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -8024.268% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -4976.858% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -32.929% |
| Autolus Therapeutics plc | 263.9 Million USD | -27.233% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -3103.358% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -277.867% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -615.956% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | 4.841% |
| GRI Bio, Inc. | 2.69 Million USD | -12349.981% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -41375.077% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -979.978% |
| IGM Biosciences, Inc. | 220.17 Million USD | -52.503% |
| INmune Bio, Inc. | 18.86 Million USD | -1680.172% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -30.918% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1160.335% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -12251.944% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -10136.243% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -474.418% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -249.188% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -26.835% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 59.202% |
| Verastem, Inc. | 71.18 Million USD | -371.695% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -582.805% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -770.382% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -586.209% |
| Histogen Inc. | 5.69 Million USD | -5793.909% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -7556.321% |
| Surrozen, Inc. | 8.14 Million USD | -4022.48% |
| Organovo Holdings, Inc. | 2.74 Million USD | -12118.923% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -106883.413% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -497.149% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -1933.527% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -557.057% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -40507.831% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -164.964% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -3005.13% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -122.532% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -12778.081% |
| Apollomics, Inc. | 14.15 Million USD | -2272.472% |
| Amarin Corporation plc | 279.58 Million USD | -20.097% |
| Mesoblast Limited | 188.79 Million USD | -77.849% |
| Turnstone Biologics Corp. | 14.14 Million USD | -2273.311% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -85.729% |
| Synaptogenix, Inc. | 5.52 Million USD | -5972.482% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -4950.782% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -97.39% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3823.904% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -19006.483% |
| Exelixis, Inc. | 678.44 Million USD | 50.508% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1308.338% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -104.684% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 43.492% |
| NLS Pharmaceutics AG | 10.68 Million USD | -3043.91% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -20580.752% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -762.579% |
| Gritstone bio, Inc. | 125.91 Million USD | -166.66% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2187.926% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -6498.558% |
| Avid Bioservices, Inc. | 275.66 Million USD | -21.804% |
| Insmed Incorporated | 1.66 Billion USD | 79.794% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -4264.114% |
| MediWound Ltd. | 27.18 Million USD | -1135.061% |
| OmniAb, Inc. | 87.4 Million USD | -284.183% |
| Alector, Inc. | 487.66 Million USD | 31.147% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 16.775% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -1722.393% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -775.032% |
| Zai Lab Limited | 240.17 Million USD | -39.804% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 46.707% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1048.856% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -253.162% |
| Immunic, Inc. | 25.36 Million USD | -1223.62% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -384.973% |
| Veracyte, Inc. | 93.71 Million USD | -258.28% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -12732.173% |
| FibroGen, Inc. | 585.72 Million USD | 42.674% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1831.634% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -51314.537% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -5837.203% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 95.614% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -3995.828% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -299.629% |
| TG Therapeutics, Inc. | 169.08 Million USD | -98.584% |
| Galecto, Inc. | 5.89 Million USD | -5594.98% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -3953.308% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 87.176% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1064.999% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -2560.455% |
| XBiotech Inc. | 8.39 Million USD | -3898.761% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2187.926% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -531.395% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | 7.527% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -1148.981% |
| Theravance Biopharma, Inc. | 169 Million USD | -98.679% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 72.378% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 32.902% |
| Vaxxinity, Inc. | 30.94 Million USD | -985.109% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 65.472% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -5467.402% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 54.944% |
| NexImmune, Inc. | 5.08 Million USD | -6504.262% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -90309.646% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -10820.085% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 95.275% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -6414.824% |
| Scopus BioPharma Inc. | 7.45 Million USD | -4404.38% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -1177.006% |
| Ainos, Inc. | 7.39 Million USD | -4441.059% |
| Pluri Inc. | 34.11 Million USD | -884.334% |
| Prothena Corporation plc | 135.01 Million USD | -148.692% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -38.121% |
| Celularity Inc. | 102.92 Million USD | -226.221% |
| Rallybio Corporation | 9.43 Million USD | -3458.457% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1273.598% |
| MeiraGTx Holdings plc | 319.99 Million USD | -4.933% |
| Omeros Corporation | 403.25 Million USD | 16.733% |
| Humacyte, Inc. | 114.67 Million USD | -192.802% |
| Immunocore Holdings plc | 228.15 Million USD | -47.168% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -6787.713% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -337.55% |
| Blueprint Medicines Corporation | 918.64 Million USD | 63.449% |
| CalciMedica, Inc. | 4.02 Million USD | -8236.048% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -1823.997% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -117.834% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -291.27% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -20.873% |
| Pulmatrix, Inc. | 15.96 Million USD | -2003.464% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -2028.802% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1264.61% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -33.878% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -561.158% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 72.265% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -956.464% |
| Nutriband Inc. | 1.07 Million USD | -31021.521% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -3057.867% |
| Vor Biopharma Inc. | 59.1 Million USD | -468.11% |
| Roivant Sciences Ltd. | 773.95 Million USD | 56.615% |
| Evogene Ltd. | 17.99 Million USD | -1766.459% |
| ProKidney Corp. | 29.21 Million USD | -1049.288% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -366.492% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -47528.95% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 82.224% |
| CorMedix Inc. | 11.91 Million USD | -2717.497% |
| BioLineRx Ltd. | 50.7 Million USD | -562.254% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -124.661% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -279.661% |
| Atai Life Sciences N.V. | 49.16 Million USD | -582.999% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -977.853% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -1769.369% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -169.405% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -5838.734% |
| MediciNova, Inc. | 3.89 Million USD | -8528.329% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -1736.95% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -22221.955% |
| GeoVax Labs, Inc. | 3.51 Million USD | -9439.413% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 15.477% |
| Biomea Fusion, Inc. | 30.69 Million USD | -994.089% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 87.663% |
| Mereo BioPharma Group plc | 15.96 Million USD | -2003.596% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -976.171% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -472.176% |
| Absci Corporation | 58.3 Million USD | -475.906% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1662.789% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -947.271% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -355.043% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -283.819% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -894.303% |
| Allakos Inc. | 74.79 Million USD | -348.94% |
| Imunon, Inc. | 8.53 Million USD | -3836.216% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1392.271% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -192.457% |
| BioAtla, Inc. | 48.98 Million USD | -585.453% |
| NLS Pharmaceutics AG | 10.68 Million USD | -3043.91% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -11982.62% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -157.095% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -2262.125% |
| XOMA Corporation | 145.58 Million USD | -130.647% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -897.404% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -388.338% |
| aTyr Pharma, Inc. | 31.59 Million USD | -962.683% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -443.125% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -646.75% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -593.723% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -11599.512% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -4015.902% |
| Akari Therapeutics, Plc | 4.58 Million USD | -7224.956% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1793.495% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 79.643% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -83031.802% |
| UroGen Pharma Ltd. | 243.52 Million USD | -37.883% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -4.575% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -12058.933% |
| Orgenesis Inc. | 35.53 Million USD | -844.916% |
| Entera Bio Ltd. | 1.37 Million USD | -24249.239% |
| GH Research PLC | 6.7 Million USD | -4910.834% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -4837.882% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -1683.576% |
| Xencor, Inc. | 283.55 Million USD | -18.415% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -11146.234% |
| Replimune Group, Inc. | 113.21 Million USD | -196.585% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -8837.046% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -224.327% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -83031.802% |
| Portage Biotech Inc. | 4.45 Million USD | -7445.528% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -22221.955% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1356.729% |
| OncoCyte Corporation | 49.29 Million USD | -581.115% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -8016.795% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -42004.418% |
| Purple Biotech Ltd. | 10 Million USD | -3256.082% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -5703.249% |
| scPharmaceuticals Inc. | 57.26 Million USD | -486.396% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -2610.489% |
| HilleVax, Inc. | 78.9 Million USD | -325.523% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -6549.03% |
| Tharimmune, Inc. | 1.81 Million USD | -18399.586% |
| Genprex, Inc. | 3.25 Million USD | -10218.21% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -1138.158% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -6312.834% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -162898.058% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -93548.828% |
| OKYO Pharma Limited | 7.42 Million USD | -4424.767% |
| Savara Inc. | 37.19 Million USD | -802.818% |
| Curis, Inc. | 57.61 Million USD | -482.823% |
| Daré Bioscience, Inc. | 26.32 Million USD | -1175.267% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -756.576% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -23153.186% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1512.834% |
| BeiGene, Ltd. | 2.23 Billion USD | 84.968% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -1477.168% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -27.965% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1478.34% |
| Erasca, Inc. | 78.61 Million USD | -327.136% |
| bluebird bio, Inc. | 424.62 Million USD | 20.924% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -51143.796% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 82.235% |
| DBV Technologies S.A. | 42.8 Million USD | -684.523% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -51143.796% |
| Moderna, Inc. | 4.57 Billion USD | 92.656% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -4700.229% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -20176.329% |
| Molecular Templates, Inc. | 31.17 Million USD | -977.206% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -1867.053% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 42.905% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -169.689% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -1123.807% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -821.045% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -503.534% |
| MacroGenics, Inc. | 154.2 Million USD | -117.744% |
| RenovoRx, Inc. | 4.46 Million USD | -7418.495% |
| Adicet Bio, Inc. | 37.12 Million USD | -804.569% |
| Prime Medicine, Inc. | 60.78 Million USD | -452.445% |
| Aditxt, Inc. | 28.53 Million USD | -1076.858% |
| Adagene Inc. | 45.16 Million USD | -643.371% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -185718.562% |
| Quantum-Si incorporated | 26.63 Million USD | -1160.846% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 51.865% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -10936.412% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -192.078% |
| SciSparc Ltd. | 1.59 Million USD | -20951.787% |
| Vericel Corporation | 127.7 Million USD | -162.931% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -5933.826% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -293.373% |
| Generation Bio Co. | 171.63 Million USD | -95.639% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -2807.152% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -702.697% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -32.876% |
| Invivyd, Inc. | 51.71 Million USD | -549.307% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -265.065% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -5061.615% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -344.76% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -32786.974% |
| 2seventy bio, Inc. | 310.12 Million USD | -8.271% |
| ADMA Biologics, Inc. | 193.97 Million USD | -73.102% |
| Clene Inc. | 38.95 Million USD | -762.047% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -829.282% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -30.664% |
| GeoVax Labs, Inc. | 3.51 Million USD | -9439.413% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -76.48% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -2656.858% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -69.308% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -2653.436% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -597.919% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -535.446% |
| Vir Biotechnology, Inc. | 369.85 Million USD | 9.214% |
| Evaxion Biotech A/S | 17.61 Million USD | -1805.925% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -108.649% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -119.195% |
| Trevena, Inc. | 48.26 Million USD | -595.736% |
| Surrozen, Inc. | 8.14 Million USD | -4022.48% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1454.878% |
| Cingulate Inc. | 10.36 Million USD | -3140.81% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -12110.036% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -800.397% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -9262.167% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -2453.43% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -5.856% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1251.266% |
| Clearmind Medicine Inc. | 3.61 Million USD | -9201.254% |
| Kronos Bio, Inc. | 54.2 Million USD | -519.501% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -613.764% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1375.307% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1572.941% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1380.725% |
| ImmunityBio, Inc. | 1.09 Billion USD | 69.206% |
| Korro Bio, Inc. | 51.75 Million USD | -548.817% |
| Kineta, Inc. | 7.22 Million USD | -4549.349% |
| BioVie Inc. | 9.7 Million USD | -3360.848% |
| Codexis, Inc. | 49.94 Million USD | -572.278% |
| Celularity Inc. | 102.92 Million USD | -226.221% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -248.869% |
| Celcuity Inc. | 51.45 Million USD | -552.625% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -97171.679% |
| Cibus, Inc. | 206.11 Million USD | -62.906% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -690.526% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -1174.824% |
| IN8bio, Inc. | 8.77 Million USD | -3727.816% |
| Kodiak Sciences Inc. | 213.59 Million USD | -57.205% |
| Annexon, Inc. | 47.11 Million USD | -612.628% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -274.997% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -248.417% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -2352.889% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 87.102% |
| Eyenovia, Inc. | 19.78 Million USD | -1597.529% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -89.612% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -4271.514% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1293.319% |
| Arcellx, Inc. | 339.75 Million USD | 1.17% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -2722.121% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -36.75% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -3411.199% |
| Moolec Science SA | 13.94 Million USD | -2307.798% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -678.124% |
| Geron Corporation | 146.12 Million USD | -129.784% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -564.482% |
| Royalty Pharma plc | 6.29 Billion USD | 94.668% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -744.167% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -113952.023% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -13547.866% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -77.513% |
| Humacyte, Inc. | 114.67 Million USD | -192.802% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1055.815% |
| 89bio, Inc. | 59.96 Million USD | -459.972% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -1168.851% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -27974.916% |
| Genelux Corporation | 8.42 Million USD | -3887.838% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -4797.55% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -146.316% |
| Notable Labs, Ltd. | 4.42 Million USD | -7484.73% |
| Liquidia Corporation | 73.13 Million USD | -359.099% |
| Mustang Bio, Inc. | 17.61 Million USD | -1805.761% |
| Immunovant, Inc. | 48.95 Million USD | -585.887% |
| Quantum-Si incorporated | 26.63 Million USD | -1160.846% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -774.804% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -10721.012% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -354.605% |
| Acasti Pharma Inc. | 11.55 Million USD | -2805.391% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1385.227% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -12251.944% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -810.53% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -24537.926% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -5408.136% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1252.027% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1348.309% |
| PepGen Inc. | 34.63 Million USD | -869.582% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -2664.954% |
| United Therapeutics Corporation | 1.18 Billion USD | 71.597% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -4707.789% |
| Solid Biosciences Inc. | 38.45 Million USD | -773.098% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3823.904% |
| Immuneering Corporation | 12 Million USD | -2696.186% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -106883.413% |
| Silo Pharma, Inc. | 1.56 Million USD | -21296.955% |
| Belite Bio, Inc | 4.21 Million USD | -7873.783% |
| XOMA Corporation | 145.58 Million USD | -130.647% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -13729.325% |
| Bionomics Limited | 10.15 Million USD | -3205.298% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1462.403% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1365.439% |
| uniQure N.V. | 624.01 Million USD | 46.191% |
| Cassava Sciences, Inc. | 14.19 Million USD | -2265.453% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -185718.562% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -97.302% |
| Forte Biosciences, Inc. | 3.66 Million USD | -9059.193% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -128755.681% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -4876.671% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -4271.514% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1831.634% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -3077.29% |
| Altimmune, Inc. | 16.54 Million USD | -1929.962% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 45.641% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1365.439% |
| Compugen Ltd. | 55.77 Million USD | -502.019% |
| Peak Bio, Inc. | 20.75 Million USD | -1517.935% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -203.971% |
| Benitec Biopharma Inc. | 4.96 Million USD | -6666.949% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -112.728% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -346.665% |
| Zura Bio Limited | 21.29 Million USD | -1477.005% |
| PolyPid Ltd. | 17.46 Million USD | -1822.235% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -198.736% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -346.665% |
| Instil Bio, Inc. | 99.8 Million USD | -236.446% |
| argenx SE | 444.95 Million USD | 24.536% |
| Immunome, Inc. | 28.65 Million USD | -1071.666% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -3927.54% |
| Verona Pharma plc | 58.84 Million USD | -470.65% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -2220.017% |
| Shattuck Labs, Inc. | 14.85 Million USD | -2159.748% |
| CervoMed Inc. | 2.59 Million USD | -12835.621% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -6789.126% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -2536.432% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -3087.243% |
| Moolec Science SA | 13.94 Million USD | -2307.798% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -14227.947% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -503.965% |
| AnaptysBio, Inc. | 364.28 Million USD | 7.826% |
| Design Therapeutics, Inc. | 11.95 Million USD | -2708.431% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -2547.241% |
| NeurAxis, Inc. | 1.91 Million USD | -17454.721% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -762.557% |
| Lumos Pharma, Inc. | 13.33 Million USD | -2418.383% |
| Achilles Therapeutics plc | 19.08 Million USD | -1659.187% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -2220.017% |
| 180 Life Sciences Corp. | 5.38 Million USD | -6132.838% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1323.504% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1375.307% |
| Nutriband Inc. | 1.07 Million USD | -31021.521% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -997.379% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -2213.941% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 16.323% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -934.016% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -2473.174% |
| Palisade Bio, Inc. | 2.73 Million USD | -12159.073% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -6292.081% |
| Beam Therapeutics Inc. | 478.38 Million USD | 29.811% |
| Neurogene Inc. | 36.54 Million USD | -818.701% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 15.624% |
| AEON Biopharma, Inc. | 159.88 Million USD | -110.006% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -604.672% |
| Sesen Bio, Inc. | 30.98 Million USD | -983.708% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -1193.386% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -4316.817% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -71.544% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -74.831% |
| Athira Pharma, Inc. | 30.05 Million USD | -1017.131% |
| Vaccinex, Inc. | 5.94 Million USD | -5550.892% |
| HCW Biologics Inc. | 15.05 Million USD | -2130.782% |
| XOMA Corporation | 145.58 Million USD | -130.647% |
| Nektar Therapeutics | 267.04 Million USD | -25.737% |
| Arvinas, Inc. | 644.6 Million USD | 47.909% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1793.495% |
| Merus N.V. | 102.15 Million USD | -228.706% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -129.434% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -253.003% |
| Rezolute, Inc. | 11.73 Million USD | -2761.565% |
| Clene Inc. | 38.95 Million USD | -762.047% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -11692.455% |
| BeyondSpring Inc. | 48.26 Million USD | -595.635% |
| Synlogic, Inc. | 32.89 Million USD | -920.751% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -2197.79% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -20449.327% |
| Peak Bio, Inc. | 20.75 Million USD | -1517.935% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -429.123% |
| Krystal Biotech, Inc. | 39.71 Million USD | -745.485% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 10.851% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -237.229% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -77495.522% |
| MannKind Corporation | 721.36 Million USD | 53.453% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1403.362% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -15996.644% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -227.299% |
| Gossamer Bio, Inc. | 249.14 Million USD | -34.77% |
| CohBar, Inc. | 1.03 Million USD | -32384.874% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -3041.323% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1662.789% |
| Legend Biotech Corporation | 589.93 Million USD | 43.082% |
| Mural Oncology plc | 37.92 Million USD | -785.298% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -153.156% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -14528.646% |
| Disc Medicine, Inc. | 22.87 Million USD | -1367.873% |
| Champions Oncology, Inc. | 28.03 Million USD | -1097.703% |
| REGENXBIO Inc. | 262.22 Million USD | -28.047% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -9895.261% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -2578.921% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -2399.891% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1483.476% |
| Vaxart, Inc. | 34.02 Million USD | -886.851% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1546.827% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1076.845% |
| Cellectis S.A. | 249.57 Million USD | -34.539% |
| Longeveron Inc. | 5.33 Million USD | -6191.475% |
| Repare Therapeutics Inc. | 41.81 Million USD | -702.927% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 86.04% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -456.215% |
| Revolution Medicines, Inc. | 262.39 Million USD | -27.965% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -15836.213% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -3792.604% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -2745.318% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -2291.056% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -15510.228% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 93.48% |
| Denali Therapeutics Inc. | 122.96 Million USD | -173.071% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -5933.826% |
| Veru Inc. | 32.81 Million USD | -923.311% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -4788.281% |
| Cingulate Inc. | 10.36 Million USD | -3140.81% |
| Passage Bio, Inc. | 39.26 Million USD | -755.219% |
| Context Therapeutics Inc. | 4.19 Million USD | -7910.468% |
| Exicure, Inc. | 8.54 Million USD | -3827.664% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1037.915% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -3102.136% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1423.415% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -106.015% |
| Nuvalent, Inc. | 31.82 Million USD | -955.136% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -5178.147% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -432.792% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -1765.422% |
| OmniAb, Inc. | 87.4 Million USD | -284.183% |
| Anew Medical, Inc. | 8.24 Million USD | -3974.062% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -776.949% |
| Lipocine Inc. | 2.63 Million USD | -12659.245% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -1178.076% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -735.014% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1160.335% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -289.739% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -6116.923% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -305.786% |
| Ocugen, Inc. | 23.98 Million USD | -1300.058% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -623.546% |
| Q32 Bio Inc. | 233.12 Million USD | -44.031% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -3603.684% |
| Alumis Inc. Common Stock | 53.5 Million USD | -527.595% |
| Equillium, Inc. | 27.95 Million USD | -1101.044% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -62.531% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -5867.585% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -5374.935% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -113.427% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -383.597% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -3266.445% |
| Dominari Holdings Inc. | 4.63 Million USD | -7144.358% |
| Edesa Biotech, Inc. | 1.84 Million USD | -18132.475% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1035.644% |
| Bio-Techne Corporation | 744.34 Million USD | 54.889% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -166.28% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | 2.52% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -727.544% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1059.568% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -263.551% |
| Nkarta, Inc. | 105.6 Million USD | -217.97% |
| BioCardia, Inc. | 4.59 Million USD | -7215.381% |
| Iterum Therapeutics plc | 32.66 Million USD | -928.033% |